

Skinvisible, Inc.
Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.
Research library
WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.


Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.


A global leader in embedded software and products for the Internet of Things, offering Android based smart connected devices, 5G and end to end cloud services.


Develops proprietary technology that changes how video is streamed, consumed, transferred and stored, including advanced video compression and portable hardware systems.


A Tokyo based software development company offering SaaS products globally, plus data analytics that help enterprises create tailored web experiences.


Designs, develops and sells conferencing, collaboration and network streaming solutions for voice and visual communications.


Formerly Newgioco Group, Inc. An international technology firm providing betting platforms for leisure gaming operators in Europe and the U.S., from lottery and casino gaming to sports betting.


A global cannabis cultivation, extraction, distribution and branded product company with expertise across all major cannabis manufacturing processes.


A Calgary-based oil and gas company focused on the Bakken Shale and Three Forks Sanish formations of the Williston Basin. It holds over 66,000 net acres in North Dakota and Saskatchewan, and its production reached about 1,100 barrels of oil equivalent per day in late 2010.
Supplies networked devices for wireless cashless payment in vending machines, laundry equipment, kiosks and more, along with energy management products. It has strategic relationships with MasterCard, Coca-Cola Enterprises, AT&T and First Data.
A biopharmaceutical company in New Jersey and Montreal developing therapeutic and diagnostic products for the aging population. It completed Phase II trials of its NX-1207 drug candidate for enlarged prostate and sells AlzheimAlert, a urine test that aids the diagnosis of Alzheimer's disease.

A development-stage biotechnology company developing adult stem cell therapies for neurodegenerative diseases such as Parkinson's, ALS and multiple sclerosis. Its NurOwn technology, licensed from Tel Aviv University, turns a patient's own bone marrow stem cells into neural-like cells.

A specialty pharmaceutical company in Hayward, California, serving the acute care and critical care hospital markets. Formed in 1999 through the merger of RiboGene and Cypros Pharmaceutical, it markets four acute care products and has critical care drugs in clinical development.
WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer